These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35725386)

  • 1. HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection.
    Tarragó D; González I; González-Escribano MF
    BMC Genomics; 2022 Jun; 23(1):455. PubMed ID: 35725386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
    Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
    Shirane M; Yawata N; Motooka D; Shibata K; Khor SS; Omae Y; Kaburaki T; Yanai R; Mashimo H; Yamana S; Ito T; Hayashida A; Mori Y; Numata A; Murakami Y; Fujiwara K; Ohguro N; Hosogai M; Akiyama M; Hasegawa E; Paley M; Takeda A; Maenaka K; Akashi K; Yokoyama WM; Tokunaga K; Yawata M; Sonoda KH
    Front Immunol; 2022; 13():1008220. PubMed ID: 36341392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
    Sullivan LC; Westall GP; Widjaja JM; Mifsud NA; Nguyen TH; Meehan AC; Kotsimbos TC; Brooks AG
    PLoS One; 2015; 10(8):e0135972. PubMed ID: 26302084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
    Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
    J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients.
    Vietzen H; Hartenberger S; Jaksch P; Puchhammer-Stöckl E
    J Heart Lung Transplant; 2021 Sep; 40(9):900-904. PubMed ID: 34183227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18.
    Prod'homme V; Tomasec P; Cunningham C; Lemberg MK; Stanton RJ; McSharry BP; Wang EC; Cuff S; Martoglio B; Davison AJ; Braud VM; Wilkinson GW
    J Immunol; 2012 Mar; 188(6):2794-804. PubMed ID: 22345649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do variations in the HLA-E ligand encoded by UL40 distinguish individuals susceptible to HCMV disease?
    Waters S; Allcock RJN; Lee S; Downing J; Ariyanto I; Leary S; Munyard K; Irish A; Price P
    Hum Immunol; 2023 Feb; 84(2):75-79. PubMed ID: 36456304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell receptors regulate responses of HLA-E-restricted T cells.
    Sullivan LC; Nguyen THO; Harpur CM; Stankovic S; Kanagarajah AR; Koutsakos M; Saunders PM; Cai Z; Gray JA; Widjaja JML; Lin J; Pietra G; Mingari MC; Moretta L; Samir J; Luciani F; Westall GP; Malmberg KJ; Kedzierska K; Brooks AG
    Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33893172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
    Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
    J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
    Ulbrecht M; Martinozzi S; Grzeschik M; Hengel H; Ellwart JW; Pla M; Weiss EH
    J Immunol; 2000 May; 164(10):5019-22. PubMed ID: 10799855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
    Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
    Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells.
    Rousselière A; Charreau B
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and child human leukocyte antigens in congenital cytomegalovirus infection.
    Rovito R; Claas FHJ; Haasnoot GW; Roelen DL; Kroes ACM; Vossen ACTM
    J Reprod Immunol; 2018 Apr; 126():39-45. PubMed ID: 29477013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.
    Mazzarino P; Pietra G; Vacca P; Falco M; Colau D; Coulie P; Moretta L; Mingari MC
    Eur J Immunol; 2005 Nov; 35(11):3240-7. PubMed ID: 16224817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus-Specific T Cell Epitope Recognition in Congenital Cytomegalovirus Mother-Infant Pairs.
    Materne EC; Lilleri D; Garofoli F; Lombardi G; Furione M; Zavattoni M; Gibson L
    Front Immunol; 2020; 11():568217. PubMed ID: 33329532
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.
    Allard M; Tonnerre P; Nedellec S; Oger R; Morice A; Guilloux Y; Houssaint E; Charreau B; Gervois N
    PLoS One; 2012; 7(11):e50951. PubMed ID: 23226431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.
    Pietra G; Romagnani C; Mazzarino P; Falco M; Millo E; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10896-901. PubMed ID: 12960383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.